These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 8921822

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Primary medical therapy of micro- and macroprolactinomas in men.
    Pinzone JJ, Katznelson L, Danila DC, Pauler DK, Miller CS, Klibanski A.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3053-7. PubMed ID: 10999785
    [Abstract] [Full Text] [Related]

  • 28. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
    Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830
    [Abstract] [Full Text] [Related]

  • 29. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study.
    Verhelst JA, Froud AL, Touzel R, Wass JA, Besser GM, Grossman AB.
    Acta Endocrinol (Copenh); 1991 Oct; 125(4):385-91. PubMed ID: 1683503
    [Abstract] [Full Text] [Related]

  • 30. Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up.
    Wu ZB, Yu CJ, Su ZP, Zhuge QC, Wu JS, Zheng WM.
    J Neurosurg; 2006 Jan; 104(1):54-61. PubMed ID: 16509147
    [Abstract] [Full Text] [Related]

  • 31. Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.
    Chattopadhyay A, Bhansali A, Masoodi SR.
    Pituitary; 2005 Jan; 8(2):147-54. PubMed ID: 16379032
    [Abstract] [Full Text] [Related]

  • 32. Dopamine receptor agonists for treating prolactinomas.
    Colao A, di Sarno A, Pivonello R, di Somma C, Lombardi G.
    Expert Opin Investig Drugs; 2002 Jun; 11(6):787-800. PubMed ID: 12036422
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Long term treatment with CV 205-502 in patients with prolactin-secreting pituitary macroadenomas.
    Serri O, Beauregard H, Lesage J, Pedneault L, Comtois R, Jilwan N, Somma M, Vachon L, Brownell J.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):682-7. PubMed ID: 2394774
    [Abstract] [Full Text] [Related]

  • 37. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Delgrange E, Sassolas G, Perrin G, Jan M, Trouillas J.
    Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
    [Abstract] [Full Text] [Related]

  • 38. A cross-over study with the two novel dopaminergic drugs cabergoline and quinagolide in hyperprolactinemic patients.
    Giusti M, Porcella E, Carraro A, Cuttica M, Valenti S, Giordano G.
    J Endocrinol Invest; 1994 Jan; 17(1):51-7. PubMed ID: 7911813
    [Abstract] [Full Text] [Related]

  • 39. The assessment of cabergoline efficacy and tolerability in patients with pituitary prolactinoma type.
    Bolko P, Jaskuła M, Waśko R, Wołuń M, Sowiński J.
    Pol Arch Med Wewn; 2003 May; 109(5):489-95. PubMed ID: 14768178
    [Abstract] [Full Text] [Related]

  • 40. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
    Tyson D, Reggiardo D, Sklar C, David R.
    Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.